Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid c
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.